Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HP INCHPQ · Entity 642 | Director · Interim CEO | February 03, 2026 | February 05, 2026 |
| KEYCORP /NEW/KEY · Entity 3220 | Director | July 01, 2021 | July 06, 2021 |
| MARSH & MCLENNAN COMPANIES, INC.MRSH · Entity 1501 | Director | August 15, 2026 | August 18, 2026 |
| TAKEDA PHARMACEUTICAL CO LTDTAK · Entity 2662 | Director | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HP INC
Report date February 03, 2026 · Filed February 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 344,149 |
Reported balance
After 2026-02-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-03 · Grant · Acquired 344,149 · Balance 344,149 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2: On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.
F2: On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock.
KEYCORP /NEW/
Report date July 01, 2021 · Filed July 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 19,587 |
Reported balance
After 2021-07-01 transaction · row 1
1 source rowRow 1 · 2021-07-01 · Exercise / conversion · Acquired 6,781 · Balance 19,587 F1: Each Deferred Share is the economic equivalent of one Common Share. |
| Deferred SharesSEC Table II · derivative / convertible security · Expires 2021-07-01 | Direct | 27,263 |
Reported balance
After 2021-07-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-07-01 · Exercise / conversion · Disposed 6,781 · Balance 27,263 F1: Each Deferred Share is the economic equivalent of one Common Share. F3: Includes approximately 288 dividend-equivalent deferred shares accrued under the Deferred Share Plan in June 2021. |
| Common SharesSEC Table I · non-derivative | IndirectBy Trust | 11,778 |
Reported balance
Holding disclosure · report date 2021-07-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 11,778 F2: These shares are held in a living trust. The reporting person is trustee of the trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Share is the economic equivalent of one Common Share.
F2: These shares are held in a living trust. The reporting person is trustee of the trust.
F3: Includes approximately 288 dividend-equivalent deferred shares accrued under the Deferred Share Plan in June 2021.
MARSH & MCLENNAN COMPANIES, INC.
Report date August 15, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,617 |
Reported balance
After 2026-08-15 transaction · row 1
1 source rowRow 1 · 2026-08-15 · Grant · Acquired 192 · Balance 1,617 F1: Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan.
TAKEDA PHARMACEUTICAL CO LTD
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 4,595 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 3,800 · Balance 4,595 F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. |
| Tax Obligation AwardSEC Table II · derivative / convertible security · Expires 2029-06-01 | Direct | 1,319 |
Reported balance
After 2026-07-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-01 · Grant · Acquired 1,319 · Balance 1,319 F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029.
F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HUMANA INC
Report date July 01, 2024 · Filed July 01, 2024
Section 16 reporting ended · disclosed 2024-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | Direct | 85,130 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 85,130 F8: Includes 21,786 restricted stock units granted on 2/21/24, representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. |
| Humana CommonSEC Table I · non-derivative | IndirectSee Footnote | 25,000 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 25,000 F9: Shares transferred to GRAT effective January 30, 2024 in which reporting person is sole trustee. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $350.79 · Expires 2027-02-24 | Direct | 13,430 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 13,430 F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $376.61 · Expires 2028-02-22 | Direct | 30,425 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 30,425 F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments on 2/22/22, 2/22/23, & 2/22/24. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $425.06 · Expires 2029-02-21 | Direct | 23,734 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 23,734 F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments on 2/21/23, 2/21/24, & 2/21/25. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $510.24 · Expires 2030-02-24 | Direct | 26,484 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 26,484 F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,184 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 2,184 F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,573 |
Reported balance
Holding disclosure · report date 2024-07-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 4,573 F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments.
F2: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments on 2/22/22, 2/22/23, & 2/22/24.
F3: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments on 2/21/23, 2/21/24, & 2/21/25.
F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
F5: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F6: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
F7: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
F8: Includes 21,786 restricted stock units granted on 2/21/24, representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
F9: Shares transferred to GRAT effective January 30, 2024 in which reporting person is sole trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2026 Filed Aug 18, 2026 20:01 UTC | MARSH & MCLENNAN COMPANIES, INC. MRSH · Entity 1501 | GrantCommon Stock | 192 | $188.45 | $36,181.44 |
DisclosureSEC source: 0000062709-26-000217 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,617 F1 · kind: Acquired in connection with director fees pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:12 UTC | TAKEDA PHARMACEUTICAL CO LTD TAK · Entity 2662 | GrantTax Obligation Award · Derivative | 1,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000268 · wk-form4_1783375918.xml · derivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,319 Underlying: Ordinary Shares · 1,319 shares Expires 2029-06-01 F2 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:12 UTC | TAKEDA PHARMACEUTICAL CO LTD TAK · Entity 2662 | GrantAmerican Depositary Shares | 3,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000268 · wk-form4_1783375918.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,595 F1 · kind: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:03 UTC | MARSH & MCLENNAN COMPANIES, INC. MRSH · Entity 1501 | GrantCommon Stock | 1,349 | $159.28 | $214,868.72 |
DisclosureSEC source: 0000062709-26-000150 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,425 F1 · kind: Annual stock award of 1,349 shares pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 22:12 UTC | HP INC HPQ · Entity 642 | GrantRestricted Stock Units · Derivative | 344,149 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001185643-26-000002 · form4-02052026_100240.xml · derivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · Interim CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,149 Underlying: Common Stock · 344,149 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · price: On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.exercise_date: On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.expiration_date: On 2/3/2026, the reporting person was granted 344,149 RSUs, all of which vest on 2/3/2027. Dividend equivalent units accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| April 14, 2025 Filed Apr 16, 2025 21:09 UTC | HP INC HPQ · Entity 642 | GrantCommon Stock | 4,784 | $24.04 | $115,007.36 |
DisclosureSEC source: 0000950170-25-054852 · ownership.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,825 F2 · shares: On 04/14/2025, the reporting person was granted 4,784 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. Read SEC document |
| April 14, 2025 Filed Apr 16, 2025 21:09 UTC | HP INC HPQ · Entity 642 | GrantCommon Stock | 9,568 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-054852 · ownership.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,041 F1 · shares: On 04/14/2025, the reporting person was granted 9,568 restricted stock units ("RSUs"), all of which vested on the grant date. Read SEC document |
| April 22, 2024 Filed Apr 24, 2024 20:48 UTC | HP INC HPQ · Entity 642 | GrantCommon Stock | 3,791 | $27.70 | $105,010.70 |
DisclosureSEC source: 0000950172-24-000223 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,473 F2 · shares: On April 22, 2024, the reporting person was granted 3,791 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. Read SEC document |
| April 22, 2024 Filed Apr 24, 2024 20:48 UTC | HP INC HPQ · Entity 642 | GrantCommon Stock | 7,943 | $0.00 | $0.00 |
DisclosureSEC source: 0000950172-24-000223 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,682 F1 · shares: On April 22, 2024, the reporting person was granted 7,943 restricted stock units ("RSUs"), all of which vested on the grant date. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 18:10 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 8,473 | $366.11 | $3,102,007.67 |
DisclosureSEC source: 0001062993-24-004179 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,344 F11 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/22/24. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 18:10 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 22,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004179 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Includes Performance Stock Units that are not required to be reported until vest. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 18:10 UTC | HUMANA INC HUM · Entity 1429 | GrantHumana Common | 21,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004179 · form4.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,130 F8 · shares: Restricted stock units granted to reporting person on 2/21/24. F9 · balance_after: Includes 21,786 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:30 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 2,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022807 · form4.xml · derivative · entry 13 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,573 Underlying: Humana Common · 2,286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:30 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022807 · form4.xml · derivative · entry 12 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,184 Underlying: Humana Common · 2,184 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:30 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 2,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022807 · form4.xml · derivative · entry 11 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 2,465 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:30 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 900 | $463.58 | $417,222.00 |
DisclosureSEC source: 0001062993-23-022807 · form4.xml · nonDerivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,245 F9 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/23. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:30 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 2,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022807 · form4.xml · nonDerivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:30 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 860 | $463.58 | $398,678.80 |
DisclosureSEC source: 0001062993-23-022807 · form4.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,859 F9 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/23. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:30 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022807 · form4.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:30 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 970 | $463.58 | $449,672.60 |
DisclosureSEC source: 0001062993-23-022807 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,535 F9 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/23. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 15:30 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 2,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-022807 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:10 UTC | HP INC HPQ · Entity 642 | GrantCommon Stock | 3,563 | $29.47 | $105,001.61 |
DisclosureSEC source: 0001209191-23-025710 · doc4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,739 F2 · shares: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:10 UTC | HP INC HPQ · Entity 642 | GrantCommon Stock | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025710 · doc4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,176 F1 · shares: On April 24, 2023, the reporting person was granted 7,466 restricted stock units ("RSUs"), all of which vested on the grant date. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 19:19 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 17,575 | $505.85 | $8,890,232.91 |
DisclosureSEC source: 0001062993-23-005077 · form4.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,040 F11 · price: Price reported is weighted average sales price. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 19:19 UTC | HUMANA INC HUM · Entity 1429 | GrantRestricted Stock Units · Derivative | 6,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005077 · form4.xml · derivative · entry 10 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,859 Underlying: Humana Common · 6,859 shares Expires not disclosed F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 19:19 UTC | HUMANA INC HUM · Entity 1429 | GrantOptions · Derivative | 26,484 | $0.00 Strike: $510.24 | $0.00 |
DisclosureSEC source: 0001062993-23-005077 · form4.xml · derivative · entry 7 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,484 Underlying: Humana Common · 26,484 shares Expires 2030-02-24 F4 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 19:19 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 10,919 | $510.24 | $5,571,337.86 |
DisclosureSEC source: 0001062993-23-005077 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,615 F10 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 19:19 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 28,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005077 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · shares: Performance Stock Units vested on 2/24/23, not required to be reported until vest. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 2,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · derivative · entry 12 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,368 Underlying: Humana Common · 2,183 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24 F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24 Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 2,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · derivative · entry 11 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,465 Underlying: Humana Common · 2,464 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 2,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · derivative · entry 10 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 2,673 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 860 | $510.02 | $438,617.20 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,040 F8 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 2,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 970 | $510.02 | $494,719.40 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,717 F8 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 2,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 1,052 | $510.02 | $536,541.04 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,223 F8 · shares: Shares disposed of represent payment for tax liability on shares vesting 12/15/22, no value received in return. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:38 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 2,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024070 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 14:56 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 7,000 | $531.92 | $3,723,437.90 |
DisclosureSEC source: 0001062993-22-023872 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,602 F8 · price: Price reported is weighted average sales price. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 26,860 | $0.00 Strike: $350.79 | $0.00 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · derivative · entry 15 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,430 Underlying: Humana Common · 26,860 shares Expires 2027-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 13,470 | $0.00 Strike: $307.97 | $0.00 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · derivative · entry 14 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 13,470 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three annual increments. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three annual increments. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionOptions · Derivative | 372 | $0.00 Strike: $268.47 | $0.00 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · derivative · entry 13 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 372 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three annual increments. F1 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three annual increments. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | SaleHumana Common | 9,000 | $566.17 | $5,095,566.00 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 9 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,564 F12 · price: Price reported is weighted average sales price. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 20,842 | $560.14 | $11,674,437.88 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 8 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,564 F11 · shares: Shares reported represent shares swapped in for the purchase price and taxes on options exercised, using FMV on 11/2/22 for computing shares swapped for purchase price and FMV on 11/3/22 for computing shares swapped for tax liability. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 26,860 | $350.79 | $9,422,152.25 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 7 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 9,587 | $560.14 | $5,370,062.18 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,546 F11 · shares: Shares reported represent shares swapped in for the purchase price and taxes on options exercised, using FMV on 11/2/22 for computing shares swapped for purchase price and FMV on 11/3/22 for computing shares swapped for tax liability. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 13,146 | $307.97 | $4,048,507.89 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,133 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 179 | $560.14 | $100,265.06 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,987 F10 · shares: Shares reported represent shares swapped in for the purchase price of options exercised, using the FMV on 11/2/22. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 324 | $307.97 | $99,780.66 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 179 | $560.14 | $100,265.06 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,842 F10 · shares: Shares reported represent shares swapped in for the purchase price of options exercised, using the FMV on 11/2/22. Read SEC document |
| November 03, 2022 Filed Nov 7, 2022 18:56 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 372 | $268.47 | $99,870.84 |
DisclosureSEC source: 0001062993-22-021636 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.